MicroRNA-449b-5p targets HMGB1 to attenuate hepatocyte injury in liver ischemia and reperfusion
- PMID: 30805938
- DOI: 10.1002/jcp.28305
MicroRNA-449b-5p targets HMGB1 to attenuate hepatocyte injury in liver ischemia and reperfusion
Abstract
MicroRNAs (miRNAs) participate in the pathological process of liver ischemia/reperfusion (I/R) injury. MiR-449b-5p is the target miRNA of high mobility group box 1 (HMGB1). Its role and molecular mechanism in liver I/R injury remain unidentified. In this study, we found a protective effect of miR-449b-5p against hepatic I/R injury. HMGB1 expression significantly increased, whereas miR-449b-5p dramatically decreased in patients after liver transplant and in L02 cells exposed to hypoxia/reoxygenation (H/R). A dual-luciferase reporter assay confirmed the direct interaction between miR-449b-5p and the 3' untranslated region of HMGB1 messenger RNA. We also found that overexpression of miR-449b-5p significantly promoted cell viability and inhibited cell apoptosis of L02 cells exposed to H/R. Moreover, miR-449b-5p repressed HMGB1 protein expression and nuclear factor-κB (NF-κB) pathway activation in these L02 cells. In an in vivo rat model of hepatic I/R injury, overexpression of miR-449b-5p significantly decreased alanine aminotransferase and aspartate aminotransferase and inhibited the HMGB1/NF-κB pathway. Our study thus suggests that miR-449b-5p alleviated hepatic I/R injury by targeting HMGB1 and deactivating the NF-κB pathway, which may provide a novel and promising therapeutic target for hepatic I/R injury.
Keywords: HMGB1; NF-κB pathway; liver ischemia/reperfusion injury; microRNA-449b-5p.
© 2019 Wiley Periodicals, Inc.
References
REFERENCES
-
- Akbari, G., Mard, S. A., Dianat, M., & Mansouri, E. (2017). The hepatoprotective and microRNAs downregulatory effects of crocin following hepatic ischemia-reperfusion injury in rats. Oxidative Medicine and Cellular Longevity, 2017. 1702967-11
-
- Hao, W., Zhao, Z. H., Meng, Q. T., Tie, M. E., Lei, S. Q., & Xia, Z. Y. (2017). Propofol protects against hepatic ischemia/reperfusion injury via miR-133a-5p regulating the expression of MAPK6. Cell Biology International, 41(5), 495-504.
-
- Indersie, E., Lesjean, S., Hooks, K. B., Sagliocco, F., Ernault, T., Cairo, S., … Grosset, C. F. (2017). MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling. Hepatology Communications, 1(2), 168-183.
-
- Inkaya, A. C., Demir, N. A., Kolgelier, S., Sumer, S., Demir, L. S., Ural, O., … Arpaci, A. (2017). Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B? Medicine (Baltimore), 96(36), e7547.
-
- Keyel, P. A. (2014). How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. Cytokine, 69(1), 136-145.
Grants and funding
LinkOut - more resources
Full Text Sources